BDBM752691 1-cyclopropyl-5-methyl-8-[[(1R)- 1-[3-(1,1-difluoro-2-hydroxy-2- methyl-propyl)-2-fluoro- phenyl]ethyl]amino]spiro[pyrrolo [2,3-g]phthalazine-3,4''- tetrahydropyran]-2-one::US20250197407, Compound 121

SMILES Cc1nnc(N[C@H](C)c2cccc(C(F)(F)C(C)(C)O)c2F)c2cc3c(cc12)C1(CCOCC1)C(=O)N3C1CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752691   

TargetKRas/Son of Sevenless Homolog 1(Human)
Jazz Pharmaceuticals Ireland

US Patent
LigandPNGBDBM752691(1-cyclopropyl-5-methyl-8-[[(1R)- 1-[3-(1,1-difluor...)
Affinity DataIC50: 6.31nMAssay Description:The capacity of compounds to inhibit SOS1 binding to KRAS-WT (wild-type) was quantified using a FRET-based protein-protein interaction assay. The ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent